Objective: To establish the evaluation criteria for the clinical application of human serum albumin in pediatrics

and analyze and evaluate the clinical application status of human serum albumin according to the criteria. Methods: Firstly

the evaluation index of pediatric human serum albumin rational application was determined by Likert five subscale method. Secondly

according to the evaluation index

the clinical application evaluation standard of human serum albumin was established. Finally

according to the established evaluation criteria

the clinical application status of 127 non-surgical inpatients who used human serum albumin from June 2019 to May 2020 was analyzed and evaluated. Results: According to the main indicators of human serum albumin evaluation criteria

127 medical orders were evaluated. There were 21 cases (38. 18%) of not flushing tube when continuous intravenous drip with other drugs

18 cases (32. 73%) of unreasonable dosage or administration route

8 cases (14. 55%) who did not meet the indications for the treatment of hypoproteinemia

6 cases (10. 91%) with no indication or inappropriate indication

and 2 cases (3. 64%) of unreasonable dripping speed or solvent. Conclusion: The evaluation standard of clinical application of human serum albumin in pediatrics is established by Likert five subscale method

and the unreasonable factors of clinical application of human serum albumin are evaluated and analyzed

to promote the rational use of human serum albumin in the clinic.